These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15047143)

  • 1. Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione.
    Onozaki A; Midorikawa S; Sanada H; Hayashi Y; Baba T; Katoh T; Watanabe T
    Biochem Biophys Res Commun; 2004 Apr; 317(1):24-9. PubMed ID: 15047143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of ethanol on rat mesangial cell proliferation via protein kinase C pathway.
    Segawa K; Minami K; Uezono Y; Shiraishi M; Shigematsu A
    Alcohol Clin Exp Res; 2002 Mar; 26(3):358-62. PubMed ID: 11923589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response.
    Morrison J; Knoll K; Hessner MJ; Liang M
    Physiol Genomics; 2004 May; 17(3):271-82. PubMed ID: 15039483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats.
    Weissgarten J; Berman S; Efrati S; Rapoport M; Averbukh Z; Feldman L
    Nephrol Dial Transplant; 2006 May; 21(5):1198-204. PubMed ID: 16449288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants reverse the antiproliferative effect of high glucose and advanced glycosylation end products in cultured rat mesangial cells.
    Trachtman H; Futterweit S; Prenner J; Hanon S
    Biochem Biophys Res Commun; 1994 Feb; 199(1):346-52. PubMed ID: 8123033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions.
    Suzaki Y; Yoshizumi M; Kagami S; Nishiyama A; Ozawa Y; Kyaw M; Izawa Y; Kanematsu Y; Tsuchiya K; Tamaki T
    Kidney Int; 2004 May; 65(5):1749-60. PubMed ID: 15086914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside GM3 inhibits the high glucose- and TGF-beta1-induced proliferation of rat glomerular mesangial cells.
    Kwak DH; Lee S; Kim SJ; Ahn SH; Song JH; Choo YK; Choi BK; Jung KY
    Life Sci; 2005 Sep; 77(20):2540-51. PubMed ID: 15939439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions.
    Premanand C; Rema M; Sameer MZ; Sujatha M; Balasubramanyam M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2179-84. PubMed ID: 16639030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes.
    Lee EY; Chung CH; Kim JH; Joung HJ; Hong SY
    Nephrol Dial Transplant; 2006 Jun; 21(6):1496-503. PubMed ID: 16484238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism for the negative regulation of cell proliferation by ganglioside GM3 in high glucose-treated glomerular mesangial cells.
    Rho YI; Kwak DH; Lee S; Ahn SH; Baek SH; Song JH; Choo YK; Choi BK; Jung KY
    Life Sci; 2004 May; 75(1):51-62. PubMed ID: 15102521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy.
    Nakagawa T; Sato W; Sautin YY; Glushakova O; Croker B; Atkinson MA; Tisher CC; Johnson RJ
    J Am Soc Nephrol; 2006 Mar; 17(3):736-45. PubMed ID: 16436494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.
    Eremina V; Cui S; Gerber H; Ferrara N; Haigh J; Nagy A; Ema M; Rossant J; Jothy S; Miner JH; Quaggin SE
    J Am Soc Nephrol; 2006 Mar; 17(3):724-35. PubMed ID: 16436493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of glucose on proliferation and collagen synthesis in cultured rat mesangial cells].
    Oshima S; Yoshizawa N
    Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):871-81. PubMed ID: 1484406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
    Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
    Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.
    Kim YS; Xu ZG; Reddy MA; Li SL; Lanting L; Sharma K; Adler SG; Natarajan R
    J Am Soc Nephrol; 2005 Feb; 16(2):352-62. PubMed ID: 15615821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway.
    Katavetin P; Miyata T; Inagi R; Tanaka T; Sassa R; Ingelfinger JR; Fujita T; Nangaku M
    J Am Soc Nephrol; 2006 May; 17(5):1405-13. PubMed ID: 16597689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-dependent synthesis of vascular endothelial growth factor is impaired by high glucose.
    Dulak J; Tomala K; Loboda A; Józkowicz A
    Life Sci; 2004 Oct; 75(21):2573-86. PubMed ID: 15363662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.